Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Nabi hepatitis C drug shows promise in chimpanzee study

Sep. 6, 1999

Shenyang Pharmaceutical University synthesizes new antiulcer benzimidazoles

Sep. 3, 1999

New ulcer drug approved for the first time in Japan

Sep. 1, 1999

Lotronex NDA gets priority review from FDA

Sep. 1, 1999

Eisai's proton pump inhibitor approved in E.U. for GERD maintenance

Sep. 1, 1999

Glaxo Wellcome proposes to discontinue Wellferon

Aug. 31, 1999

News from ACS: hepatitis C viral protease inhibitor BILN-303-SE

Aug. 30, 1999

5-HT4 receptor ligands studied extensively at Roche Bioscience

Aug. 30, 1999

Incara subsidiary licenses rights to liver progenitor cell technology

Aug. 30, 1999

Tanabe Seiyaku pursues integrin receptor antagonists, with interesting results

Aug. 25, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...